Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.

Saved in:
Bibliographic Details
Title: Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.
Authors: Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar. hsc2001@qatar-med.cornell.edu.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. hsc2001@qatar-med.cornell.edu., Ayoub HH; Mathematics Program, Department of Mathematics, Statistics and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar., Coyle P; Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK., Tang P; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Hasan MR; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada., Yassine HM; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al Thani AA; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kanaani Z; Hamad Medical Corporation, Doha, Qatar., Al-Kuwari E; Hamad Medical Corporation, Doha, Qatar., Jeremijenko A; Hamad Medical Corporation, Doha, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar., Latif AN; Hamad Medical Corporation, Doha, Qatar., Shaik RM; Hamad Medical Corporation, Doha, Qatar., Abdul-Rahim HF; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Nasrallah GK; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kuwari MG; Primary Health Care Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar., Butt AA; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA., Al-Romaihi HE; Ministry of Public Health, Doha, Qatar., Al-Thani MH; Ministry of Public Health, Doha, Qatar., Al-Khal A; Hamad Medical Corporation, Doha, Qatar., Bertollini R; Ministry of Public Health, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar.
Source: BMC infectious diseases [BMC Infect Dis] 2025 Aug 17; Vol. 25 (1), pp. 1028. Date of Electronic Publication: 2025 Aug 17.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40820125
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chemaitelly+H%22">Chemaitelly H</searchLink>; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar. hsc2001@qatar-med.cornell.edu.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. hsc2001@qatar-med.cornell.edu.<br /><searchLink fieldCode="AU" term="%22Ayoub+HH%22">Ayoub HH</searchLink>; Mathematics Program, Department of Mathematics, Statistics and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Coyle+P%22">Coyle P</searchLink>; Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.<br /><searchLink fieldCode="AU" term="%22Tang+P%22">Tang P</searchLink>; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Hasan+MR%22">Hasan MR</searchLink>; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22Yassine+HM%22">Yassine HM</searchLink>; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al+Thani+AA%22">Al Thani AA</searchLink>; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Kanaani+Z%22">Al-Kanaani Z</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Kuwari+E%22">Al-Kuwari E</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Jeremijenko+A%22">Jeremijenko A</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Kaleeckal+AH%22">Kaleeckal AH</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Latif+AN%22">Latif AN</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Shaik+RM%22">Shaik RM</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Abdul-Rahim+HF%22">Abdul-Rahim HF</searchLink>; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Nasrallah+GK%22">Nasrallah GK</searchLink>; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Kuwari+MG%22">Al-Kuwari MG</searchLink>; Primary Health Care Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Butt+AA%22">Butt AA</searchLink>; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Al-Romaihi+HE%22">Al-Romaihi HE</searchLink>; Ministry of Public Health, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Thani+MH%22">Al-Thani MH</searchLink>; Ministry of Public Health, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Khal+A%22">Al-Khal A</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Bertollini+R%22">Bertollini R</searchLink>; Ministry of Public Health, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Abu-Raddad+LJ%22">Abu-Raddad LJ</searchLink>; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100968551%22">BMC infectious diseases</searchLink> [BMC Infect Dis] 2025 Aug 17; Vol. 25 (1), pp. 1028. <i>Date of Electronic Publication: </i>2025 Aug 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968551 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2334 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712334%22">14712334 </searchLink><i>NLM ISO Abbreviation: </i>BMC Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40820125
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12879-025-11410-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1028
    Titles:
      – TitleFull: Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chemaitelly H
      – PersonEntity:
          Name:
            NameFull: Ayoub HH
      – PersonEntity:
          Name:
            NameFull: Coyle P
      – PersonEntity:
          Name:
            NameFull: Tang P
      – PersonEntity:
          Name:
            NameFull: Hasan MR
      – PersonEntity:
          Name:
            NameFull: Yassine HM
      – PersonEntity:
          Name:
            NameFull: Al Thani AA
      – PersonEntity:
          Name:
            NameFull: Al-Kanaani Z
      – PersonEntity:
          Name:
            NameFull: Al-Kuwari E
      – PersonEntity:
          Name:
            NameFull: Jeremijenko A
      – PersonEntity:
          Name:
            NameFull: Kaleeckal AH
      – PersonEntity:
          Name:
            NameFull: Latif AN
      – PersonEntity:
          Name:
            NameFull: Shaik RM
      – PersonEntity:
          Name:
            NameFull: Abdul-Rahim HF
      – PersonEntity:
          Name:
            NameFull: Nasrallah GK
      – PersonEntity:
          Name:
            NameFull: Al-Kuwari MG
      – PersonEntity:
          Name:
            NameFull: Butt AA
      – PersonEntity:
          Name:
            NameFull: Al-Romaihi HE
      – PersonEntity:
          Name:
            NameFull: Al-Thani MH
      – PersonEntity:
          Name:
            NameFull: Al-Khal A
      – PersonEntity:
          Name:
            NameFull: Bertollini R
      – PersonEntity:
          Name:
            NameFull: Abu-Raddad LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 08
              Text: 2025 Aug 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2334
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC infectious diseases
              Type: main
ResultId 1